John Neate, Chief Executive at The Prostate Cancer Charity, spoke to the Daily Telegraph, BBC Online and The Sun about the preliminary results of a trial of almost 800 men who took abiraterone acetate and lived almost four months longer than men given a placebo.

Read more

Dr Kate Holmes, Research Manager at The Prostate Cancer Charity, spoke to the Daily Mail about new research carried out by the University of Illinois, which revealed that a chemical found in babies' bottles increase the risk of men developing prostate cancer later in life.

Read more

Our comments on new research from the University of Illinois which suggests that the chemical Bisphenol A, used in the production of plastics, can increase the risk of developing prostate cancer in rats.

Read more

We comment on new research published in The Lancet into a new drug, cabazitaxel, which can extend the lives of men with advanced prostate cancer that no longer responds to hormone therapies by an average of 2.4 months.

Read more

Cabazitaxel

Dr Sarah Cant, Head of Policy and Campaigns at The Prostate Cancer Charity, spoke to the Daily Mail and the Daily Telegraph, about cabazitaxel,  a new drug which could  give men with advanced prostate cancer two extra months of life.

Read more

Talk Sport

John Robertson, a Support & Information Specialist Helpline Nurse at The Prostate Cancer Charity, joined presenter Mike Parry's morning show on Talk Sport alongside Olympic swimmer Mark Foster to raise awareness of prostate cancer.

Read more